Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

22.19

+0.21 (0.96%)

At close: Aug 1, 2025, 4:00 PM

23.00

+0.81 (3.65%)

After-hours: Aug 1, 2025, 5:31 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Novel Therapeutics	7.02M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	1.99%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	7.02M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	1.99%	Log In	Log In	Log In	Log In	Upgrade